ASCO 2022 Conference Coverage
Playback speed
10 seconds
Lecture Summary - ASCO 2022 on the Phase 3 AcceleRET Lung Study: 1L Pralsetinib in RET Fusion+ Advanced/Metastatic NSCLC
By
ASCO 2022 Conference Coverage
FEATURING
Filippo de Marinis
By
ASCO 2022 Conference Coverage
FEATURING
Filippo de Marinis
19 views
July 14, 2022
Login to view comments.
Click here to Login
Lung